• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌的治疗方式

Treatment modalities in endometrial cancer.

作者信息

Amant Frederic, Moerman Philippe, Neven Patrick, Timmerman Dirk, Van Limbergen Erik, Vergote Ignace

机构信息

Leuven Cancer Institute (LKI), UZ Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.

出版信息

Curr Opin Oncol. 2007 Sep;19(5):479-85. doi: 10.1097/CCO.0b013e32827853c0.

DOI:10.1097/CCO.0b013e32827853c0
PMID:17762575
Abstract

PURPOSE OF REVIEW

Endometrial cancer is the most common malignancy of the female genital tract. This review highlights new insights and these will change current practice.

RECENT FINDINGS

Surgery is the cornerstone of the treatment of endometrial cancer but the metastatic pattern is different for types 1 and 2. The surgical staging procedure therefore depends on subtype. Type 2 endometrial cancers often metastasize to the lymph nodes and peritoneal cavity and patients should undergo a staging procedure similar to that performed for ovarian cancer. Laparoscopic staging and treatment for endometrial cancer appears to be safe and effective. Adequate staging also serves to appropriately tailor adjuvant treatment modalities that benefit high-risk patients only. Recent data suggest adequate staging to improve the overall survival. In addition, following complete surgical staging, recent studies emphasize the benefit for adjuvant chemotherapy in early stage serous endometrial cancer. Adjuvant chemotherapy appears to be more effective than radiotherapy for type 1 cancers. In the primarily advanced or recurrent setting, hormonal treatment may be beneficial. Doxorubicin-cisplatin is still the standard chemotherapy regime used in many centres; paclitaxel-containing regimes also appear to show promise.

SUMMARY

Recent data shed new light on the current concepts of tumour spread, surgical staging and adjuvant treatment modalities for endometrial cancer.

摘要

综述目的

子宫内膜癌是女性生殖道最常见的恶性肿瘤。本综述重点介绍了新见解,这些见解将改变当前的治疗实践。

最新发现

手术是子宫内膜癌治疗的基石,但1型和2型的转移模式不同。因此,手术分期程序取决于亚型。2型子宫内膜癌常转移至淋巴结和腹腔,患者应接受类似于卵巢癌的分期程序。腹腔镜分期及治疗子宫内膜癌似乎是安全有效的。充分的分期也有助于合理调整辅助治疗方式,仅使高危患者受益。近期数据表明充分分期可提高总体生存率。此外,在完成手术分期后,近期研究强调了早期浆液性子宫内膜癌辅助化疗的益处。对于1型癌症,辅助化疗似乎比放疗更有效。在主要为晚期或复发的情况下,激素治疗可能有益。多柔比星-顺铂仍是许多中心使用的标准化疗方案;含紫杉醇的方案似乎也显示出前景。

总结

近期数据为子宫内膜癌肿瘤扩散、手术分期及辅助治疗方式的当前概念提供了新的线索。

相似文献

1
Treatment modalities in endometrial cancer.子宫内膜癌的治疗方式
Curr Opin Oncol. 2007 Sep;19(5):479-85. doi: 10.1097/CCO.0b013e32827853c0.
2
Chemotherapy for high-risk early-stage endometrial cancer.高危早期子宫内膜癌的化疗
Curr Opin Obstet Gynecol. 2007 Feb;19(1):42-7. doi: 10.1097/GCO.0b013e32801127b7.
3
Update in the management of endometrial cancer.子宫内膜癌管理的最新进展。
Cancer J. 2002 May-Jun;8 Suppl 1:S31-40.
4
Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.子宫内膜癌的辅助化疗:随机试验综述
Clin Oncol (R Coll Radiol). 2008 Aug;20(6):463-9. doi: 10.1016/j.clon.2008.04.001. Epub 2008 May 7.
5
[Endometrial cancer -- suggestions for the update of the guidelines].[子宫内膜癌——指南更新建议]
Zentralbl Gynakol. 2006 Feb;128(1):18-22. doi: 10.1055/s-2006-921361.
6
A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.晚期子宫内膜癌序贯多模式治疗及临床结局的多中心评估
Gynecol Oncol. 2009 Sep;114(3):442-7. doi: 10.1016/j.ygyno.2009.06.005. Epub 2009 Jun 26.
7
[Hormonal therapy and chemotherapy of endometrial cancer].[子宫内膜癌的激素治疗与化疗]
Zentralbl Gynakol. 2002 Jan;124(1):45-50. doi: 10.1055/s-2002-20309.
8
Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?ⅠB期子宫内膜癌。淋巴结切除术能否替代辅助放疗?
Strahlenther Onkol. 2007 Nov;183(11):600-4. doi: 10.1007/s00066-007-1801-3.
9
[Treatment strategies for endometrial cancer].
Zentralbl Gynakol. 2004 Oct;126(5):306-11. doi: 10.1055/s-2004-822704.
10
[Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].盆腔淋巴结清扫术作为早期子宫内膜癌(I期)中复发性淋巴转移高风险患者辅助放疗的替代方案
Minerva Ginecol. 2009 Feb;61(1):1-12.

引用本文的文献

1
Photodynamic priming overcomes platinum resistance from short-term exposure to select perfluoroalkyl substances in endometrial cancer cell lines.光动力预处理克服了子宫内膜癌细胞系短期暴露于特定全氟烷基物质所产生的铂耐药性。
Photochem Photobiol. 2025 Mar 10. doi: 10.1111/php.14073.
2
Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study.病态肥胖对II型子宫内膜癌结局的影响:一项队列研究
Indian J Surg Oncol. 2022 Sep;13(3):453-458. doi: 10.1007/s13193-022-01503-z. Epub 2022 Jan 17.
3
Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer.
肥胖子宫内膜癌女性淋巴结受累预测生物标志物的鉴定
Front Oncol. 2021 Jul 7;11:695404. doi: 10.3389/fonc.2021.695404. eCollection 2021.
4
Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment.在子宫内膜癌治疗中,对靶向cMet的RNAi治疗性miR-26a-5p进行双重抑制以及针对EGFR的免疫治疗。
Ann Transl Med. 2021 Jan;9(1):5. doi: 10.21037/atm-20-3166.
5
Influence of VEGFR and LHCGR on endometrial adenocarcinoma.血管内皮生长因子受体(VEGFR)和促黄体生成素/绒毛膜促性腺激素受体(LHCGR)对子宫内膜腺癌的影响。
Oncol Lett. 2016 Sep;12(3):2092-2098. doi: 10.3892/ol.2016.4906. Epub 2016 Jul 22.
6
The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review.肥胖对子宫内膜癌患者手术结局的影响:一项系统评价
J Gynecol Surg. 2016 Jun 1;32(3):149-157. doi: 10.1089/gyn.2015.0114.
7
Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review.术前检测子宫内膜癌淋巴结状态的诊断准确性:系统评价。
Cancer Imaging. 2013 Jul 22;13(3):314-22. doi: 10.1102/1470-7330.2013.0032.
8
Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report.使用不可逆电穿孔对子宫内膜癌骶前复发进行姑息治疗:一例报告
J Med Case Rep. 2013 May 13;7:128. doi: 10.1186/1752-1947-7-128.
9
Adjuvant chemotherapy for endometrial cancer after hysterectomy.子宫切除术后子宫内膜癌的辅助化疗。
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD003175. doi: 10.1002/14651858.CD003175.pub2.
10
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells.CD133 的表观遗传调控及 CD133 阳性和阴性子宫内膜癌细胞的致瘤性。
Reprod Biol Endocrinol. 2010 Dec 1;8:147. doi: 10.1186/1477-7827-8-147.